 Open Access Article
 Open Access Article
Kai Liu, 
Qiao Jin, 
Shuang Chen and 
Pei Nian Liu*
Shanghai Key Laboratory of Functional Materials Chemistry, Key Lab for Advanced Materials, School of Chemistry and Molecular Engineering, East China University of Science and Technology, Meilong Road 130, Shanghai, 200237, China. E-mail: liupn@ecust.edu.cn
First published on 5th January 2017
A novel example of AgSCF3-mediated oxidative radical trifluoromethylthiolation of α,α-diaryl allylic alcohols is presented, producing various α-aryl-β-trifluoromethylthiolated carbonyl ketones via radical neophyl rearrangement under mild conditions. This protocol involves formation of C(Ar)–C(sp3) and C(sp3)–S bonds in one step and tolerates a wide range of symmetrical and nonsymmetrical α,α-diaryl allylic alcohols.
In 2014, the first radical silver-mediated oxidative aryltrifluoromethylthiolation of activated alkenes was reported by Wang group (Scheme 1a).7a Subsequently, an intramolecular oxytrifluoromethylthiolation of unactivated alkenes was reported (Scheme 1b).7b Soon afterward, the Qing group demonstrated direct trifluoromethylthiolation of an unactivated terminal alkene, affording various allyl trifluoromethyl sulfides (Scheme 1c).7c In the following year, the same group reported another radical protocol for the trifluoromethylthiolation of quinones (Scheme 1d).7d Recently, the Nevado group has reported a silver-catalyzed radical cascade trifluoromethylthiolation affording highly functionalized heterocyclic scaffolds (Scheme 1e).7e Despite these achievements, new methods involving difunctionalization-type trifluoromethylthiolation of alkenes remain highly desirable.
Recently, the neophyl rearrangement as an efficient and ingenious strategy to constructing multiple chemical structures and reorganizing molecular skeletons has attracted increasing attention.9–14 Inspired by the Tu semipinacol rearrangement protocol15 and recent literatures for forming β-trifluoromethyl ketones9 and previous advances in silver-mediated radical additions,16 we speculated that a neophyl-type rearrangement could be triggered after adding SCF3 radical to α,α-diaryl allylic alcohols, generating α-aryl-β-trifluoromethylthiolated carbonyl ketones which suffered from poor yield in previous literature.17 As part of our continuing efforts at introducing fluorine-containing groups into organic molecules,18 we report here a novel SCF3 radical-initiated radical neophyl rearrangement of α,α-diaryl allylic alcohols to afford trifluoromethylthiolated carbonyl ketones under mild conditions (Scheme 1f).
| Entry | Oxidant | Base | Solvent | Yieldb (%) | 
|---|---|---|---|---|
| a Reactions were performed in sealed tubes containing 1a (0.20 mmol), 2a (0.30 mmol), oxidant (2 equiv.), base (1.0 equiv.), solvent (2 mL) under N2 at 65 °C for 5 h. N. D. = not detected.b Isolated yield.c K2S2O8 (1.5 equiv.) was used.d Pyridine (2 equiv.) was used.e Pyridine (0.5 equiv.) was used. | ||||
| 1 | PhI(OAc)2 | None | CH3CN | N. D. | 
| 2 | TBHP | None | CH3CN | N. D. | 
| 3 | NFSI | None | CH3CN | N. D. | 
| 4 | Mn(OAc)3 | None | CH3CN | N. D. | 
| 5 | (NH4)2S2O8 | None | CH3CN | 15 | 
| 6 | Na2S2O8 | None | CH3CN | 22 | 
| 7 | K2S2O8 | None | CH3CN | 26 | 
| 8c | K2S2O8 | None | CH3CN | 30 | 
| 9c | K2S2O8 | None | DCE | Trace | 
| 10c | K2S2O8 | None | EA | 11 | 
| 11c | K2S2O8 | None | NMP | 20 | 
| 12c | K2S2O8 | None | DMF | 13 | 
| 13c | K2S2O8 | None | DMSO | 10 | 
| 14c | K2S2O8 | K2CO3 | CH3CN | Trace | 
| 15c | K2S2O8 | HMPA | CH3CN | Trace | 
| 16c | K2S2O8 | DABCO | CH3CN | Trace | 
| 17c | K2S2O8 | DBU | CH3CN | Trace | 
| 18c | K2S2O8 | (i-Pr)2NEt | CH3CN | 45 | 
| 19c | K2S2O8 | Pyridine | CH3CN | 82 | 
| 20c,d | K2S2O8 | Pyridine | CH3CN | 74 | 
| 21c,e | K2S2O8 | Pyridine | CH3CN | 76 | 
| 22 | None | Pyridine | CH3CN | 0 | 
After determining the standard reaction conditions, we explored the scope of this difunctionalization protocol with various α,α-diaryl allylic alcohols (1), and the corresponding products 3a–3u were obtained in moderate to good isolated yields (Table 2). Note that the minor regioisomers 3f′, 3g′, 3i′, 3j′, 3l′, 3m′ and 3n′, in which R1 migrated instead of R2, were observed as byproducts in the reactions of corresponding substrates and the yields are indicated in the parentheses. When the symmetric allylic alcohols containing para-substituted bromo-group or chloro-group underwent rearrangement, the corresponding α-aryl-β-trifluoromethylthiolated carbonyl ketones 3b and 3c were obtained in respective yields of 72% and 63%. Similarly, the symmetric allylic alcohol substituted by para-OPh gave moderate 51% yield. When allylic alcohol substituted by meta-OMe was used as the substrate, no obvious substitution effect was observed and 3e was obtained in 79% yield.
| a Reaction conditions: 1a (0.20 mmol), 2a (0.30 mmol), K2S2O8 (0.30 mmol), pyridine (0.20 mmol), CH3CN (2 mL), 5 h, 65 °C under N2.b Isolated yields of products 3.c The yields of minor regioisomer 3′, in which R1 migrated instead of R2, were shown in the parentheses (determined by 1H NMR).d 3j and its isomer 3j′ were not separable. | 
|---|
|  | 
The allylic alcohols with a Ph group and a p-substituted-Ph group underwent p-substituted-Ph group migration as the major process, giving the corresponding products 3f–3h in 47–88% yield. Interestingly, allylic alcohols with a Ph group and a m-Cl–Ph group or a m-OMe–Ph group proceeded via the migration of the more electron-deficient aryl group, delivered the products 3i and 3j in respective yields of 47% and 45%. Allylic alcohols with a Ph group and an o-methylphenyl group delivered the Ph group-migration product 3k in 45% yield. Interestingly, allylic alcohols containing two different substituted aryl groups, also worked as substrates in the reaction, which selectively generated products 3l via migration of the 3,4-disubstituted-Ph group. For substrates with meta or para and meta substituents, the more electron-deficient aryl group migrated preferentially to afford the desired products 3m and 3n in respective yields of 56% and 57%. This unique selectivity suggested that the reaction might involve a radical neophyl rearrangement process rather than a simple semipinacol rearrangement.9 In the reactions generating 3o and 3p, migration of the Ph group took precedence over the pyren-2-yl and the naphthalene-2-yl, giving the respective yields of 33% and 74%. Gratifyingly, the Ph- and thiophen-2-yl-substituted allylic alcohol also worked well and afforded mainly the thiophen-2-yl-migration product 3q in good yield. Notably, the allylic alcohols with a tolyl or Ph attached to the vinyl group were also tolerated, affording the target products 3r–3u in 31–36% yield.
To gain further understanding of the reaction mechanism, the control experiments were performed (Scheme 2). When 2 equiv. of 2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPO) or 2,6-di-tert-butyl-4-methylphenol (BHT) were added to the reaction, the desired transformation was completely inhibited (Scheme 2a and b). This observation is consistent with the hypothesis that the reaction proceeds via a radical pathway through single-electron transfer. When CuSCF3 was used as the SCF3 source, the reaction led to no product, indicating that silver plays a vital role in this transformation (Scheme 2c).
|  | ||
| Scheme 2 Mechanistic studies of radical addition and radical neophyl rearrangement cascade reaction. | ||
On the basis of the experimental results and previous reports,6,10–14 a plausible mechanism is proposed as depicted in Scheme 3. AgSCF3 is oxidized by K2S2O8 firstly to generate the SCF3 radical.6 Subsequent intermolecular addition of the SCF3 radical to the double bond of allylic alcohol 1a affords radical intermediate A. Within radical intermediate A, neophyl rearrangement of the aryl group occurs via spiro[2,5]octadienyl radical B to produce intermediate C.10–14 Another single-electron transfer from intermediate C to Ag(II) oxidant generates intermediate D, which affords product 3a by release of a proton.
![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) 20 were prepared according to the literature methods. Other chemicals were obtained from commercial sources, and were used without further purification. Chemical shifs (δ, ppm) in the 1H NMR spectra were recorded using TMS as internal standard. Chemical shifts in 13C{1H} NMR spectra were internally referenced to CHCl3 (δ = 77.16 ppm).
20 were prepared according to the literature methods. Other chemicals were obtained from commercial sources, and were used without further purification. Chemical shifs (δ, ppm) in the 1H NMR spectra were recorded using TMS as internal standard. Chemical shifts in 13C{1H} NMR spectra were internally referenced to CHCl3 (δ = 77.16 ppm).
![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) :
:![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) 1). 1H NMR (400 MHz, CDCl3) δ 3.22 (1H, dd, J = 5.6, 14.0 Hz), 3.64 (1H, dd, J = 9.2, 14.0 Hz), 4.92 (1H, dd, J = 5.6, 9.2 Hz), 7.24–7.40 (5H, m), 7.36–7.40 (2H, m), 7.47–7.51 (2H, m), 7.92–7.95 (1H, m); 13C NMR (100 MHz, CDCl3) δ 32.8, 54.6, 128.2, 128.3, 128.8, 129.0, 129.6, 131.4 (q, J = 304 Hz) 133.6, 135.9, 137.2, 197.5; 19F NMR (CDCl3, 376 MHz) δ −41.3; HRMS (EI, TOF) calcd for C16H13F3OS+ [M]+: 310.0639, found: 310.0638.
1). 1H NMR (400 MHz, CDCl3) δ 3.22 (1H, dd, J = 5.6, 14.0 Hz), 3.64 (1H, dd, J = 9.2, 14.0 Hz), 4.92 (1H, dd, J = 5.6, 9.2 Hz), 7.24–7.40 (5H, m), 7.36–7.40 (2H, m), 7.47–7.51 (2H, m), 7.92–7.95 (1H, m); 13C NMR (100 MHz, CDCl3) δ 32.8, 54.6, 128.2, 128.3, 128.8, 129.0, 129.6, 131.4 (q, J = 304 Hz) 133.6, 135.9, 137.2, 197.5; 19F NMR (CDCl3, 376 MHz) δ −41.3; HRMS (EI, TOF) calcd for C16H13F3OS+ [M]+: 310.0639, found: 310.0638.![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) :
:![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) 1). 1H NMR (400 MHz, CDCl3) δ 3.18 (1H, q, J = 5.7, 14.2 Hz), 3.59 (1H, q, J = 8.9, 14.2 Hz), 4.80 (1H, J = 6.8 Hz), 7.46 (2H, d, J = 7.8 Hz), 7.46 (2H, d, J = 7.7 Hz), 7.54 (2H, d, J = 7.9 Hz), 7.76 (2H, d, J = 7.8 Hz); 13C NMR (100 MHz, CDCl3) δ 32.5, 53.9, 122.7, 129.2, 129.8, 130.4, 130.7 (q, J = 304 Hz), 132.3, 132.9, 134.3, 135.8, 196.2; 19F NMR (376 MHz, CDCl3) δ −41.3; HRMS (EI, TOF) calcd for C15H10Br2O+ [M − H − SCF3]+: 363.9087, found: 363.9105.
1). 1H NMR (400 MHz, CDCl3) δ 3.18 (1H, q, J = 5.7, 14.2 Hz), 3.59 (1H, q, J = 8.9, 14.2 Hz), 4.80 (1H, J = 6.8 Hz), 7.46 (2H, d, J = 7.8 Hz), 7.46 (2H, d, J = 7.7 Hz), 7.54 (2H, d, J = 7.9 Hz), 7.76 (2H, d, J = 7.8 Hz); 13C NMR (100 MHz, CDCl3) δ 32.5, 53.9, 122.7, 129.2, 129.8, 130.4, 130.7 (q, J = 304 Hz), 132.3, 132.9, 134.3, 135.8, 196.2; 19F NMR (376 MHz, CDCl3) δ −41.3; HRMS (EI, TOF) calcd for C15H10Br2O+ [M − H − SCF3]+: 363.9087, found: 363.9105.![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) :
:![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) 1). 1H NMR (400 MHz, CDCl3) δ 3.18 (1H, dd, J = 5.8, 14.2 Hz), 3.60 (1H, dd, J = 8.9, 14.2 Hz), 4.82 (1H, t, J = 7.2 Hz), 7.20 (2H, d, J = 8.1 Hz), 7.31 (2H, d, J = 7.9 Hz), 7.38 (2H, d, J = 8.1 Hz), 7.85 (2H, d, J = 8.1 Hz); 13C NMR (100 MHz, CDCl3) δ 32.6, 53.8, 129.3, 129.5, 129.9, 130.3, 131.3 (q, J = 304 Hz), 133.9, 134.5, 135.3, 140.4, 196.1; 19F NMR (376 MHz, CDCl3) δ −41.3; HRMS (EI, TOF) calcd for C15H11Cl2O+ [M − SCF3]+: 277.0181, found: 277.0168.
1). 1H NMR (400 MHz, CDCl3) δ 3.18 (1H, dd, J = 5.8, 14.2 Hz), 3.60 (1H, dd, J = 8.9, 14.2 Hz), 4.82 (1H, t, J = 7.2 Hz), 7.20 (2H, d, J = 8.1 Hz), 7.31 (2H, d, J = 7.9 Hz), 7.38 (2H, d, J = 8.1 Hz), 7.85 (2H, d, J = 8.1 Hz); 13C NMR (100 MHz, CDCl3) δ 32.6, 53.8, 129.3, 129.5, 129.9, 130.3, 131.3 (q, J = 304 Hz), 133.9, 134.5, 135.3, 140.4, 196.1; 19F NMR (376 MHz, CDCl3) δ −41.3; HRMS (EI, TOF) calcd for C15H11Cl2O+ [M − SCF3]+: 277.0181, found: 277.0168.![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) :
:![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) 1). 1H NMR (400 MHz, CDCl3) δ 3.20 (1H, dd, J = 5.7, 14.0 Hz), 3.62 (1H, dd, J = 9.0, 14.0 Hz), 4.80 (1H, dd, J = 5.7, 9.0 Hz), 7.13 (2H, d, J = 8.2 Hz), 7.47 (2H, d, J = 8.2 Hz), 7.55 (1H, d, J = 8.4 Hz), 7.76 (2H, d, J = 8.4 Hz); 13C NMR (100 MHz, CDCl3) δ 32.9, 53.5, 117.2, 119.3, 119.5, 120.5, 123.9, 124.9, 129.5, 129.9, 130.2, 130.3, 131.4 (q, J = 304 Hz), 131.8, 155.2, 156.5, 157.5, 162.5; 19F NMR (CDCl3, 376 MHz) δ −41.2; HRMS (EI, TOF) calcd for C28H21F3O3S+ [M]+: 494.1163, found: 494.1165.
1). 1H NMR (400 MHz, CDCl3) δ 3.20 (1H, dd, J = 5.7, 14.0 Hz), 3.62 (1H, dd, J = 9.0, 14.0 Hz), 4.80 (1H, dd, J = 5.7, 9.0 Hz), 7.13 (2H, d, J = 8.2 Hz), 7.47 (2H, d, J = 8.2 Hz), 7.55 (1H, d, J = 8.4 Hz), 7.76 (2H, d, J = 8.4 Hz); 13C NMR (100 MHz, CDCl3) δ 32.9, 53.5, 117.2, 119.3, 119.5, 120.5, 123.9, 124.9, 129.5, 129.9, 130.2, 130.3, 131.4 (q, J = 304 Hz), 131.8, 155.2, 156.5, 157.5, 162.5; 19F NMR (CDCl3, 376 MHz) δ −41.2; HRMS (EI, TOF) calcd for C28H21F3O3S+ [M]+: 494.1163, found: 494.1165.![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) :
:![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) 1). 1H NMR (400 MHz, CDCl3) δ 3.22 (1H, dd, J = 5.6, 14.0 Hz), 3.63 (1H, dd, J = 9.2, 14.0 Hz), 3.76 (3H, s), 3.8 (3H, s), 4.85 (1H, dd, J = 5.6, 9.2 Hz), 6.78–6.88 (3H, m), 7.03–7.06 (1H, m), 7.22–7.30 (2H, m), 7.47–7.52 (2H, m); 13C NMR (100 MHz, CDCl3) δ 32.7, 54.7, 55.4, 55.5, 113.2, 113.3, 113.9, 120.1, 120.5, 121.6, 129.8, 130.6, 131.4 (q, J = 304 Hz), 137.2, 138.7, 159.9, 160.3, 197.2; 19F NMR (376 MHz, CDCl3) δ −41.3; HRMS (EI, TOF) calcd for C18H17F3O3S+ [M]+: 370.0850, found: 370.0853.
1). 1H NMR (400 MHz, CDCl3) δ 3.22 (1H, dd, J = 5.6, 14.0 Hz), 3.63 (1H, dd, J = 9.2, 14.0 Hz), 3.76 (3H, s), 3.8 (3H, s), 4.85 (1H, dd, J = 5.6, 9.2 Hz), 6.78–6.88 (3H, m), 7.03–7.06 (1H, m), 7.22–7.30 (2H, m), 7.47–7.52 (2H, m); 13C NMR (100 MHz, CDCl3) δ 32.7, 54.7, 55.4, 55.5, 113.2, 113.3, 113.9, 120.1, 120.5, 121.6, 129.8, 130.6, 131.4 (q, J = 304 Hz), 137.2, 138.7, 159.9, 160.3, 197.2; 19F NMR (376 MHz, CDCl3) δ −41.3; HRMS (EI, TOF) calcd for C18H17F3O3S+ [M]+: 370.0850, found: 370.0853.![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) :
:![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) 1). 1H NMR (400 MHz, CDCl3) δ 3.19 (1H, dd, J = 5.9, 14.2 Hz), 3.61 (1H, dd, J = 8.8, 14.2 Hz), 4.89 (1H, dd, J = 5.9, 8.8 Hz), 7.21–7.23 (2H, d, J = 8.5 Hz), 7.29–7.31 (2H, m), 7.39–7.43 (2H, m), 7.51–7.55 (1H, m), 7.89–7.91 (2H, m); 13C NMR (100 MHz, CDCl3) δ 32.8, 53.7, 128.9, 129.0, 129.6, 129.8, 131.3 (q, J = 304 Hz), 133.8, 134.3, 135.6, 135.7, 197.3; 19F NMR (376 MHz, CDCl3) δ −41.3; HRMS (EI, TOF) calcd for C16H12ClF3OS+ [M]+: 344.0249, found: 344.0255.
1). 1H NMR (400 MHz, CDCl3) δ 3.19 (1H, dd, J = 5.9, 14.2 Hz), 3.61 (1H, dd, J = 8.8, 14.2 Hz), 4.89 (1H, dd, J = 5.9, 8.8 Hz), 7.21–7.23 (2H, d, J = 8.5 Hz), 7.29–7.31 (2H, m), 7.39–7.43 (2H, m), 7.51–7.55 (1H, m), 7.89–7.91 (2H, m); 13C NMR (100 MHz, CDCl3) δ 32.8, 53.7, 128.9, 129.0, 129.6, 129.8, 131.3 (q, J = 304 Hz), 133.8, 134.3, 135.6, 135.7, 197.3; 19F NMR (376 MHz, CDCl3) δ −41.3; HRMS (EI, TOF) calcd for C16H12ClF3OS+ [M]+: 344.0249, found: 344.0255.![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) :
:![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) 1). 1H NMR (400 MHz, CDCl3) δ 3.19 (1H, dd, J = 5.9, 14.2 Hz), 3.61 (1H, dd, J = 8.8, 14.2 Hz), 4.87 (1H, dd, J = 5.9, 8.8 Hz), 7.14–7.18 (2H, m), 7.39–7.47 (4H, m), 7.50–7.55 (1H, m), 7.89–7.91 (2H, m); 13C NMR (100 MHz, CDCl3) δ 32.8, 53.8, 122.5, 128.9, 129.0, 129.9, 131.2 (q, J = 304 Hz), 132.8, 133.8, 135.6, 136.2, 197.2; 19F NMR (376 MHz, CDCl3) δ −41.3; HRMS (EI, TOF) calcd for C15H12BrO+ [M − SCF3]+: 287.0072, found: 287.0039.
1). 1H NMR (400 MHz, CDCl3) δ 3.19 (1H, dd, J = 5.9, 14.2 Hz), 3.61 (1H, dd, J = 8.8, 14.2 Hz), 4.87 (1H, dd, J = 5.9, 8.8 Hz), 7.14–7.18 (2H, m), 7.39–7.47 (4H, m), 7.50–7.55 (1H, m), 7.89–7.91 (2H, m); 13C NMR (100 MHz, CDCl3) δ 32.8, 53.8, 122.5, 128.9, 129.0, 129.9, 131.2 (q, J = 304 Hz), 132.8, 133.8, 135.6, 136.2, 197.2; 19F NMR (376 MHz, CDCl3) δ −41.3; HRMS (EI, TOF) calcd for C15H12BrO+ [M − SCF3]+: 287.0072, found: 287.0039.![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) :
:![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) 1). 1H NMR (400 MHz, CDCl3) δ 3.25 (1H, dd, J = 5.6, 14.2 Hz), 3.68 (1H, dd, J = 9.1, 14.2 Hz), 4.96 (1H, t, J = 6.9 Hz), 7.32–7.36 (3H, m), 7.39–7.42 (4H, m), 7.49–7.55 (5H, m), 7.97 (2H, d, J = 7.7 Hz); 13C NMR (100 MHz, CDCl3) δ 32.8, 54.1, 127.1, 127.7, 128.2, 128.6, 128.8, 128.9, 129.0, 131.4 (q, J = 304 Hz), 133.6, 135.9, 136.1, 140.3, 141.2, 197.5; 19F NMR (376 MHz, CDCl3) δ −41.3; HRMS (EI, TOF) calcd for C22H17F3OS+ [M]+: 386.0952, found: 386.0951.
1). 1H NMR (400 MHz, CDCl3) δ 3.25 (1H, dd, J = 5.6, 14.2 Hz), 3.68 (1H, dd, J = 9.1, 14.2 Hz), 4.96 (1H, t, J = 6.9 Hz), 7.32–7.36 (3H, m), 7.39–7.42 (4H, m), 7.49–7.55 (5H, m), 7.97 (2H, d, J = 7.7 Hz); 13C NMR (100 MHz, CDCl3) δ 32.8, 54.1, 127.1, 127.7, 128.2, 128.6, 128.8, 128.9, 129.0, 131.4 (q, J = 304 Hz), 133.6, 135.9, 136.1, 140.3, 141.2, 197.5; 19F NMR (376 MHz, CDCl3) δ −41.3; HRMS (EI, TOF) calcd for C22H17F3OS+ [M]+: 386.0952, found: 386.0951.![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) :
:![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) 1). 1H NMR (400 MHz, CDCl3) δ 3.20 (1H, dd, J = 4.0, 16.0 Hz), 3.63 (1H, dd, J = 8.0, 16.0 Hz), 4.90 (1H, dd, J = 4.0, 8.0 Hz), 7.16–7.18 (1H, m), 7.23–7.29 (3H, m), 7.42 (2H, d, J = 8.0 Hz), 7.54 (1H, d, J = 8.0 Hz), 7.91–7.94 (1H, m); 13C NMR (100 MHz, CDCl3) δ 32.7, 53.9, 126.5, 128.3, 128.6, 128.9, 129.0, 130.8, 131.3 (q, J = 305 Hz), 133.9, 135.4, 135.6, 139.1, 197.0; 19F NMR (376 MHz, CDCl3) δ −41.3; HRMS (EI, TOF) calcd for C16H12ClF3OS+ [M]+: 344.0249, found: 344.0251.
1). 1H NMR (400 MHz, CDCl3) δ 3.20 (1H, dd, J = 4.0, 16.0 Hz), 3.63 (1H, dd, J = 8.0, 16.0 Hz), 4.90 (1H, dd, J = 4.0, 8.0 Hz), 7.16–7.18 (1H, m), 7.23–7.29 (3H, m), 7.42 (2H, d, J = 8.0 Hz), 7.54 (1H, d, J = 8.0 Hz), 7.91–7.94 (1H, m); 13C NMR (100 MHz, CDCl3) δ 32.7, 53.9, 126.5, 128.3, 128.6, 128.9, 129.0, 130.8, 131.3 (q, J = 305 Hz), 133.9, 135.4, 135.6, 139.1, 197.0; 19F NMR (376 MHz, CDCl3) δ −41.3; HRMS (EI, TOF) calcd for C16H12ClF3OS+ [M]+: 344.0249, found: 344.0251.![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) :
:![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) 1). 1H NMR (400 MHz, CDCl3) δ 3.21 (2H, dd, J = 5.6, 14.0 Hz), 3.64 (2H, dd, J = 9.1, 14.0 Hz), 3.77 (2.68H, s), 3.80 (3.20H, s), 4.87 (2H, m), 6.78–6.80 (2H, m), 6.87 (1H, d, J = 7.6 Hz), 7.03–7.06 (1H, m), 7.22–7.41 (9H, m), 7.46–7.52 (3H, m), 7.93–7.95 (2H, m); 13C NMR (100 MHz, CDCl3) δ 32.75, 32.84, 54.6, 54.7, 55.4, 55.5, 113.2, 113.4, 113.9, 120.1, 120.6, 121.6, 128.2, 128.3, 128.8, 129.0, 129.6, 129.8, 130.6, 131.4 (q, J = 304 Hz), 133.6, 135.9, 137.2, 137.3, 138.7, 159.9, 160.4, 197.4; 19F NMR (376 MHz, CDCl3) δ −41.3; HRMS (EI, TOF) calcd for C17H15F3O2S+ [M]+: 340.0745, found: 340.0749.
1). 1H NMR (400 MHz, CDCl3) δ 3.21 (2H, dd, J = 5.6, 14.0 Hz), 3.64 (2H, dd, J = 9.1, 14.0 Hz), 3.77 (2.68H, s), 3.80 (3.20H, s), 4.87 (2H, m), 6.78–6.80 (2H, m), 6.87 (1H, d, J = 7.6 Hz), 7.03–7.06 (1H, m), 7.22–7.41 (9H, m), 7.46–7.52 (3H, m), 7.93–7.95 (2H, m); 13C NMR (100 MHz, CDCl3) δ 32.75, 32.84, 54.6, 54.7, 55.4, 55.5, 113.2, 113.4, 113.9, 120.1, 120.6, 121.6, 128.2, 128.3, 128.8, 129.0, 129.6, 129.8, 130.6, 131.4 (q, J = 304 Hz), 133.6, 135.9, 137.2, 137.3, 138.7, 159.9, 160.4, 197.4; 19F NMR (376 MHz, CDCl3) δ −41.3; HRMS (EI, TOF) calcd for C17H15F3O2S+ [M]+: 340.0745, found: 340.0749.![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) :
:![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) 1). 1H NMR (400 MHz, CDCl3) δ 2.37 (3H, s), 3.21 (1H, dd, J = 5.4, 14.0 Hz), 3.67 (1H, dd, J = 9.5, 14.0 Hz), 4.80 (1H, dd, J = 5.4, 9.5 Hz); 7.15–7.27 (4H, m), 7.28–7.32 (4H, m), 7.57 (1H, d, J = 7.7 Hz); 13C NMR (100 MHz, CDCl3) δ 21.4, 32.4, 57.0, 125.7, 128.2, 128.3, 128.5, 129.4, 131.4 (q, J = 304 Hz), 131.7, 132.0, 136.6, 137.3, 138.9, 201.2; 19F NMR (376 MHz, CDCl3) δ −41.3; HRMS (ESI, TOF) calcd for C17H15F3OS+ [M]+: 324.0796, found: 324.0798.
1). 1H NMR (400 MHz, CDCl3) δ 2.37 (3H, s), 3.21 (1H, dd, J = 5.4, 14.0 Hz), 3.67 (1H, dd, J = 9.5, 14.0 Hz), 4.80 (1H, dd, J = 5.4, 9.5 Hz); 7.15–7.27 (4H, m), 7.28–7.32 (4H, m), 7.57 (1H, d, J = 7.7 Hz); 13C NMR (100 MHz, CDCl3) δ 21.4, 32.4, 57.0, 125.7, 128.2, 128.3, 128.5, 129.4, 131.4 (q, J = 304 Hz), 131.7, 132.0, 136.6, 137.3, 138.9, 201.2; 19F NMR (376 MHz, CDCl3) δ −41.3; HRMS (ESI, TOF) calcd for C17H15F3OS+ [M]+: 324.0796, found: 324.0798.![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) :
:![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) 1). 1H NMR (400 MHz, CDCl3) δ 3.20 (1H, dd, J = 6.0, 14.2 Hz), 3.61 (1H, dd, J = 8.8, 14.2 Hz), 4.87 (1H, dd, J = 6.0, 8.8 Hz), 7.14 (1H, dd, J = 2.1, 8.3 Hz), 7.39–7.45 (4H, m), 7.53–7.57 (1H, m), 7.90–7.92 (2H, m); 13C NMR (100 MHz, CDCl3) δ 32.7, 53.2, 127.6, 128.9, 129.0, 130.1, 130.5, 131.3 (q, J = 303 Hz), 131.5, 132.7, 133.7, 134.1, 135.5, 137.2, 196.8; 19F NMR (376 MHz, CDCl3) δ −41.2; HRMS (EI, TOF) calcd for C16H11Cl2F3OS+ [M]+: 377.9860, found: 377.9865.
1). 1H NMR (400 MHz, CDCl3) δ 3.20 (1H, dd, J = 6.0, 14.2 Hz), 3.61 (1H, dd, J = 8.8, 14.2 Hz), 4.87 (1H, dd, J = 6.0, 8.8 Hz), 7.14 (1H, dd, J = 2.1, 8.3 Hz), 7.39–7.45 (4H, m), 7.53–7.57 (1H, m), 7.90–7.92 (2H, m); 13C NMR (100 MHz, CDCl3) δ 32.7, 53.2, 127.6, 128.9, 129.0, 130.1, 130.5, 131.3 (q, J = 303 Hz), 131.5, 132.7, 133.7, 134.1, 135.5, 137.2, 196.8; 19F NMR (376 MHz, CDCl3) δ −41.2; HRMS (EI, TOF) calcd for C16H11Cl2F3OS+ [M]+: 377.9860, found: 377.9865.![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) :
:![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) 1). 1H NMR (400 MHz, CDCl3) δ 3.20 (1H, dd, J = 5.7, 14.2 Hz), 3.62 (1H, dd, J = 9.0, 14.2 Hz), 3.82 (3H, s), 4.86 (1H, dd, J = 5.7, 9.0 Hz), 7.06–7.09 (1H, m), 7.20–7.22 (2H, m), 7.31 (1H, t, J = 8.0 Hz), 7.39–7.42 (1H, m), 7.43–7.49 (3H, m); 13C NMR (100 MHz, CDCl3) δ 32.8, 54.0, 55.6, 113.2, 120.4, 121.6, 123.5, 126.9, 129.8, 129.9, 131.0, 131.1, 131.3 (q, J = 304 Hz), 131.5, 137.0, 139.4, 160.0, 196.8; 19F NMR (376 MHz, CDCl3) δ −41.2; HRMS (EI, TOF) calcd for C17H14BrF3O2S+ [M]+: 417.9850, found: 417.9854.
1). 1H NMR (400 MHz, CDCl3) δ 3.20 (1H, dd, J = 5.7, 14.2 Hz), 3.62 (1H, dd, J = 9.0, 14.2 Hz), 3.82 (3H, s), 4.86 (1H, dd, J = 5.7, 9.0 Hz), 7.06–7.09 (1H, m), 7.20–7.22 (2H, m), 7.31 (1H, t, J = 8.0 Hz), 7.39–7.42 (1H, m), 7.43–7.49 (3H, m); 13C NMR (100 MHz, CDCl3) δ 32.8, 54.0, 55.6, 113.2, 120.4, 121.6, 123.5, 126.9, 129.8, 129.9, 131.0, 131.1, 131.3 (q, J = 304 Hz), 131.5, 137.0, 139.4, 160.0, 196.8; 19F NMR (376 MHz, CDCl3) δ −41.2; HRMS (EI, TOF) calcd for C17H14BrF3O2S+ [M]+: 417.9850, found: 417.9854.![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) :
:![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) 1). 1H NMR (400 MHz, CDCl3) δ 3.19 (1H, dd, J = 5.9, 14.2 Hz), 3.60 (1H, dd, J = 8.8, 14.2 Hz), 3.81 (3H, s), 3.87 (1H, dd, J = 5.9, 8.8 Hz), 7.07 (1H, dd, J = 2.2, 7.9 Hz), 7.20–7.23 (2H, m), 7.28–7.32 (3H, m), 7.44–7.48 (2H, m); 13C NMR (100 MHz, CDCl3) δ 32.7, 53.8, 55.6, 113.3, 120.2, 121.5, 129.6, 129.8, 129.9, 131.4 (q, J = 304 Hz), 134.3, 135.7, 137.0, 160.0, 197.1; 19F NMR (376 MHz, CDCl3) δ −41.3; HRMS (EI, TOF) calcd for C17H14ClF3O2S+ [M]+: 374.0355, found: 374.0358.
1). 1H NMR (400 MHz, CDCl3) δ 3.19 (1H, dd, J = 5.9, 14.2 Hz), 3.60 (1H, dd, J = 8.8, 14.2 Hz), 3.81 (3H, s), 3.87 (1H, dd, J = 5.9, 8.8 Hz), 7.07 (1H, dd, J = 2.2, 7.9 Hz), 7.20–7.23 (2H, m), 7.28–7.32 (3H, m), 7.44–7.48 (2H, m); 13C NMR (100 MHz, CDCl3) δ 32.7, 53.8, 55.6, 113.3, 120.2, 121.5, 129.6, 129.8, 129.9, 131.4 (q, J = 304 Hz), 134.3, 135.7, 137.0, 160.0, 197.1; 19F NMR (376 MHz, CDCl3) δ −41.3; HRMS (EI, TOF) calcd for C17H14ClF3O2S+ [M]+: 374.0355, found: 374.0358.![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) :
:![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) 1). 1H NMR (400 MHz, CDCl3) δ 3.37 (1H, dd, J = 4.4, 14.4 Hz), 3.84 (1H, dd, J = 10.5, 14.4 Hz), 5.97 (1H, dd, J = 4.4, 10.5 Hz), 7.21–7.26 (2H, m), 7.37 (1H, t, J = 7.4 Hz), 7.7 (1H, d, J = 8.0 Hz), 7.78–7.89 (2H, m), 7.98 (1H, d, J = 8.9 Hz), 8.03–8.09 (3H, m), 8.23 (1H, d, J = 7.4 Hz), 8.28 (1H, d, J = 7.6 Hz), 8.35 (1H, d, J = 9.3 Hz), 8.55 (1H, d, J = 9.3 Hz); 13C NMR (100 MHz, CDCl3) δ 32.4, 51.0, 121.3, 124.9, 125.1, 125.6, 125.7, 125.8, 126.1, 126.5, 127.5, 128.1, 128.2, 128.8, 128.9, 129.6, 130.8, 131.0, 131.3, 131.4, 131.7 (q, J = 303 Hz), 133.5, 135.9, 198.0; 19F NMR (376 MHz, CDCl3) δ −41.3; HRMS (EI, TOF) calcd for C26H17F3OS+ [M]+: 434.0952, found: 434.0954.
1). 1H NMR (400 MHz, CDCl3) δ 3.37 (1H, dd, J = 4.4, 14.4 Hz), 3.84 (1H, dd, J = 10.5, 14.4 Hz), 5.97 (1H, dd, J = 4.4, 10.5 Hz), 7.21–7.26 (2H, m), 7.37 (1H, t, J = 7.4 Hz), 7.7 (1H, d, J = 8.0 Hz), 7.78–7.89 (2H, m), 7.98 (1H, d, J = 8.9 Hz), 8.03–8.09 (3H, m), 8.23 (1H, d, J = 7.4 Hz), 8.28 (1H, d, J = 7.6 Hz), 8.35 (1H, d, J = 9.3 Hz), 8.55 (1H, d, J = 9.3 Hz); 13C NMR (100 MHz, CDCl3) δ 32.4, 51.0, 121.3, 124.9, 125.1, 125.6, 125.7, 125.8, 126.1, 126.5, 127.5, 128.1, 128.2, 128.8, 128.9, 129.6, 130.8, 131.0, 131.3, 131.4, 131.7 (q, J = 303 Hz), 133.5, 135.9, 198.0; 19F NMR (376 MHz, CDCl3) δ −41.3; HRMS (EI, TOF) calcd for C26H17F3OS+ [M]+: 434.0952, found: 434.0954.![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) :
:![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) 1). 1H NMR (400 MHz, CDCl3) δ 3.30 (1H, dd, J = 5.7, 14.1 Hz), 3.73 (1H, dd, J = 9.1, 141 Hz), 5.07 (1H, dd, J = 5.7, 9.1 Hz), 7.34–7.46 (3H, m), 7.46–7.49 (3H, m), 7.73 (1H, s), 7.77–7.84 (3H, m), 7.96–7.98 (2H, m); 13C NMR (100 MHz, CDCl3) δ 32.9, 54.7, 125.7, 126.6, 126.8, 127.5, 127.9, 128.0, 128.8, 129.0, 129.6, 131.5 (q, J = 304 Hz), 132.9, 133.6, 133.7, 134.7, 135.9, 197.5; 19F NMR (376 MHz, CDCl3) δ −41.3; HRMS (EI, TOF) calcd for C20H15F3OS+ [M]+: 360.0796, found: 360.0797.
1). 1H NMR (400 MHz, CDCl3) δ 3.30 (1H, dd, J = 5.7, 14.1 Hz), 3.73 (1H, dd, J = 9.1, 141 Hz), 5.07 (1H, dd, J = 5.7, 9.1 Hz), 7.34–7.46 (3H, m), 7.46–7.49 (3H, m), 7.73 (1H, s), 7.77–7.84 (3H, m), 7.96–7.98 (2H, m); 13C NMR (100 MHz, CDCl3) δ 32.9, 54.7, 125.7, 126.6, 126.8, 127.5, 127.9, 128.0, 128.8, 129.0, 129.6, 131.5 (q, J = 304 Hz), 132.9, 133.6, 133.7, 134.7, 135.9, 197.5; 19F NMR (376 MHz, CDCl3) δ −41.3; HRMS (EI, TOF) calcd for C20H15F3OS+ [M]+: 360.0796, found: 360.0797.![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) :
:![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) 1). 1H NMR (400 MHz, CDCl3) δ 3.68 (2H, d, J = 12.8 Hz), 3.77 (1H, d, J = 12.8 Hz), 7.16 (2H, d, J = 8.9 Hz), 7.30–7.38 (9H, m), 7.56 (2H, d, J = 8.6 Hz); 13C NMR (100 MHz, CDCl3) δ 42.0, 64.8, 128.4, 128.9, 129.0, 129.1, 129.2, 130.8 (q, J = 304 Hz), 131.0, 132.0, 133.5, 134.3, 136.9, 138.2, 139.3, 198.1; 19F NMR (376 MHz, CDCl3) δ −42.8; HRMS (ESI, TOF) calcd for C22H15Cl2F3NaOS+ [M + Na]+: 477.0070, found: 477.0067.
1). 1H NMR (400 MHz, CDCl3) δ 3.68 (2H, d, J = 12.8 Hz), 3.77 (1H, d, J = 12.8 Hz), 7.16 (2H, d, J = 8.9 Hz), 7.30–7.38 (9H, m), 7.56 (2H, d, J = 8.6 Hz); 13C NMR (100 MHz, CDCl3) δ 42.0, 64.8, 128.4, 128.9, 129.0, 129.1, 129.2, 130.8 (q, J = 304 Hz), 131.0, 132.0, 133.5, 134.3, 136.9, 138.2, 139.3, 198.1; 19F NMR (376 MHz, CDCl3) δ −42.8; HRMS (ESI, TOF) calcd for C22H15Cl2F3NaOS+ [M + Na]+: 477.0070, found: 477.0067.![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) :
:![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) 1). 1H NMR (400 MHz, CDCl3) δ 2.34 (3H, s), 3.65 (1H, d, J = 12.8 Hz), 3.77 (2H, d, J = 12.8 Hz), 7.14–7.18 (4H, m), 7.21 (2H, d, J = 8.4 Hz), 7.29–7.35 (4H, m), 7.55 (2H, d, J = 8.8 Hz); 13C NMR (100 MHz, CDCl3) δ 21.2, 42.0, 64.5, 128.5, 128.9, 129.1, 129.8, 131.0, 132.0, 133.7, 134.2, 135.1, 137.2, 138.4, 139.2, 199.2; 19F NMR (CDCl3, 376 MHz) δ −42.7; HRMS (EI, TOF) calcd for C22H17Cl2O+ [M]+: 367.0656, found: 367.0653.
1). 1H NMR (400 MHz, CDCl3) δ 2.34 (3H, s), 3.65 (1H, d, J = 12.8 Hz), 3.77 (2H, d, J = 12.8 Hz), 7.14–7.18 (4H, m), 7.21 (2H, d, J = 8.4 Hz), 7.29–7.35 (4H, m), 7.55 (2H, d, J = 8.8 Hz); 13C NMR (100 MHz, CDCl3) δ 21.2, 42.0, 64.5, 128.5, 128.9, 129.1, 129.8, 131.0, 132.0, 133.7, 134.2, 135.1, 137.2, 138.4, 139.2, 199.2; 19F NMR (CDCl3, 376 MHz) δ −42.7; HRMS (EI, TOF) calcd for C22H17Cl2O+ [M]+: 367.0656, found: 367.0653.![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) :
:![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) 1). 1H NMR (400 MHz, CDCl3) δ 2.34 (3H, s), 3.67 (1H, d, J = 12.8 Hz), 3.77 (2H, d, J = 12.8 Hz), 7.24–7.27 (2H, m), 7.34–7.37 (7H, m), 7.46–7.51 (4H, m); 13C NMR (100 MHz, CDCl3) δ 41.9, 64.9, 122.5, 128.2, 128.5, 129.1, 129.2, 131.3, 131.5, 132.0, 132.1, 134.0, 137.5, 138.1, 198.2; 19F NMR (CDCl3, 376 MHz) δ −42.7; HRMS (EI, TOF) calcd for C21H15Br2O+ [M]+: 440.9490, found: 440.9491.
1). 1H NMR (400 MHz, CDCl3) δ 2.34 (3H, s), 3.67 (1H, d, J = 12.8 Hz), 3.77 (2H, d, J = 12.8 Hz), 7.24–7.27 (2H, m), 7.34–7.37 (7H, m), 7.46–7.51 (4H, m); 13C NMR (100 MHz, CDCl3) δ 41.9, 64.9, 122.5, 128.2, 128.5, 129.1, 129.2, 131.3, 131.5, 132.0, 132.1, 134.0, 137.5, 138.1, 198.2; 19F NMR (CDCl3, 376 MHz) δ −42.7; HRMS (EI, TOF) calcd for C21H15Br2O+ [M]+: 440.9490, found: 440.9491.![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) :
:![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif) 1). 1H NMR (400 MHz, CDCl3) δ 2.34 (3H, s), 3.67 (1H, d, J = 12.8 Hz), 3.77 (2H, d, J = 12.8 Hz), 7.15–7.18 (2H, m), 7.23–7.26 (4H, m), 7.32–7.34 (2H, m), 7.46–7.49 (4H, m); 13C NMR (100 MHz, CDCl3) δ 41.9, 64.9, 122.5, 128.2, 128.5, 129.1, 129.2, 131.3, 131.5, 132.0, 132.1, 134.0, 137.5, 138.1, 198.2; 19F NMR (CDCl3, 376 MHz) δ −42.7; HRMS (EI, TOF) calcd for C22H17Br2O+ [M]+: 454.9646, found: 454.9644.
1). 1H NMR (400 MHz, CDCl3) δ 2.34 (3H, s), 3.67 (1H, d, J = 12.8 Hz), 3.77 (2H, d, J = 12.8 Hz), 7.15–7.18 (2H, m), 7.23–7.26 (4H, m), 7.32–7.34 (2H, m), 7.46–7.49 (4H, m); 13C NMR (100 MHz, CDCl3) δ 41.9, 64.9, 122.5, 128.2, 128.5, 129.1, 129.2, 131.3, 131.5, 132.0, 132.1, 134.0, 137.5, 138.1, 198.2; 19F NMR (CDCl3, 376 MHz) δ −42.7; HRMS (EI, TOF) calcd for C22H17Br2O+ [M]+: 454.9646, found: 454.9644.| Footnote | 
| † Electronic supplementary information (ESI) available: Detailed experimental procedure and characterization of products (H1, C13 and F19 NMR spectra). See DOI: 10.1039/c6ra25378d | 
| This journal is © The Royal Society of Chemistry 2017 |